Markets:

Overview

News

Currencies

International

Treasuries

Catalent, Inc. Common Stock (NY:CTLT)

63.48 UNCHANGED

Last Price Updated: 7:00 PM EST, Dec 17, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Catalent, Inc. Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

10 Health Care Stocks With Whale Alerts In Today's Session ↗

April 26, 2023

Via Benzinga

Why Catalent Stock Tumbled by Nearly 6% on Tuesday ↗

April 25, 2023

A warning about revenue and the abandonment of a potential suitor are recent developments that continue to hammer sentiment on the company.

Via The Motley Fool

Where Catalent Stands With Analysts ↗

April 25, 2023

Via Benzinga

Why Danaher Shares Are Falling Today ↗

April 25, 2023

Via Benzinga

eBay To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Tuesday ↗

April 25, 2023

B of A Securities cut the price target for Catalent, Inc. (NYSE: CTLT) from $78 to $49. B of A Securities analyst Derik De Bruin maintained a Neutral rating. Catalent shares fell 0.2% to $44.83 in...

Via Benzinga

Why Catalent Shares Are Falling Today ↗

April 18, 2023

Via Benzinga

Why Catalent Stock Slumped on Monday ↗

April 17, 2023

It looks like the company won't be acquired after all...at least for now.

Via The Motley Fool

Catalent's Operational Inefficiencies: Analyst Downgrades Stock, Seeks Additional Clarity ↗

April 14, 2023

Via Benzinga

Where Catalent Stands With Analysts ↗

April 03, 2023

Via Benzinga

Why Catalent Stock Dove More Than 7% Today ↗

April 18, 2023

The specialty healthcare company is having a miserable couple of days on the exchange.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For April 17, 2023 ↗

April 17, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 14, 2023

Via Benzinga

Why Catalent Stock Was on Fire This Week ↗

February 10, 2023

The shares did exceptionally well considering the company had a ho-hum quarter.

Via The Motley Fool

Looking Into Catalent's Return On Capital Employed ↗

February 08, 2023

Via Benzinga

Why Teva Pharmaceutical Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 14, 2023

Gainers SAI.TECH Global Corporation (NASDAQ: SAI) jumped 269% to $5.61 after gaining around 25% on Thursday.

Via Benzinga

US Stocks Mixed; Retail Sales Drop 1% In March ↗

April 14, 2023

U.S. stocks traded mixed this morning, following the release of economic reports. Following the market opening Friday, the Dow traded up 0.08% to 34,055.40 while the NASDAQ fell 0.10% to 12,153.84. The...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 14, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 10, 2023 ↗

April 10, 2023

Via Benzinga

Valero Energy To Rally 32%? Here Are 10 Other Analyst Forecasts For Monday ↗

April 10, 2023

Credit Suisse boosted the price target for The Boeing Company (NYSE: BA) from $200 to $220. Credit Suisse analyst Scott Deuschle maintained a Neutral rating on the stock. Boeing shares fell 0.4% to...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2023 ↗

April 04, 2023

Via Benzinga

Tesla Is S&P 500's Biggest Loser Monday As Oil Stocks Dominate Upside ↗

April 03, 2023

Tesla tumbled back below a buy point. Oil stocks dominated the upside.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For April 3, 2023 ↗

April 03, 2023

Via Benzinga

2 Clinical Research Stocks That Could Grow by More Than 10% This Year, and 1 to Watch ↗

March 25, 2023

These companies strive to bring down the cost of developing new therapies.

Via The Motley Fool

Catalent Stock Showing Improved Relative Strength Rating ↗

March 10, 2023

On Friday, Catalent stock earned a positive adjustment to its Relative Strength (RS) Rating, from 63 to 74.

Via Investor's Business Daily

Incannex Engages Catalent For Development And Manufacture Of Psilocybin Drug For Clinical Trials ↗

March 03, 2023

Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL), a pharmaceutical company developing proprietary medicinal cannabinoid products and psychedelic medicine therapies for unmet medical needs, has...

Via Benzinga

Stocks Tank After Latest Inflation Data: Here's What Got Hit The Hardest ↗

February 24, 2023

Markets traded lower during Friday’s pre-market session following the Bureau of Economic Analysis report on a 5.4% increase in the personal consumption expenditures (PCE) price index for the month of...

Via Benzinga

Nasdaq Down Over 100 Points; Tyson Foods Posts Downbeat Earnings ↗

February 06, 2023

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping over 80 points on Monday. The Dow traded down 0.15% to 33,875.74 while the NASDAQ fell 0.88% to 11,900.97. The S&P...

Via Benzinga

Why Omeros Are Trading Higher By 32%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

February 06, 2023

Gainers Secoo Holding Limited (NASDAQ: SECO) jumped 156% to $4.3600. Arqit Quantum Inc. (NASDAQ: ARQQ) gained 41.5% to $3.54.

Via Benzinga

Crude Oil Down Over 1%; Nasdaq Drops 80 Points ↗

February 06, 2023

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 80 points on Monday. The Dow traded down 0.21% to 33,853.11 while the NASDAQ fell 0.60% to 11,934.76. The S&P...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

February 06, 2023

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Catalent, Inc. Common Stock (NY:CTLT)

Headline News about Catalent, Inc. Common Stock

Starting at $3.75/week.

Subscribe Today